Tao Wang

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
No aliases are listed.
Publication record
42 papers · 478 citations · H-index 15

PAPERS

Dosimetric and Clinical Effects of Polyethylene Glycol Gel in Radical Concurrent Chemoradiotherapy for Cervical Cancer: A Phase III Prospective Multicenter Randomized Controlled Trial.
20252 citationsauthor #10
Cadonilimab, An Anti-PD-1/CTLA-4 Bi-Specific Antibody, In Combination With Chemoradiotherapy In Locally Advanced Or Isolated Metastatic Cervical Cancer: A Retrospective Study
20250 citationsauthor #3
Efficacy and safety of cadonilimab plus anti-EGFR monoclonal antibody as de-chemotherapy regimen in persistent, recurrent, or metastatic gynecologic cancer.
20240 citationsauthor #7
The efficacy of recombinant human adenovirus type 5 (H101) intra-tumor therapy in persistent/recurrent/metastatic gynecological cancer and the exploration of changes in tumor microenvironment.
20240 citationsauthor #7
The safety and efficacy of cadonilimab in the treatment of advanced and metastatic cervical cancer: A retrospective, real-world study.
20232 citationsauthor #2
Recombinant Human Adenovirus Type 5 (H101) Intra-Tumor Therapy in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer: Genomic Profiling Relating to Clinical Efficacy
20236 citationsauthor #6
The impacts of minimally invasive surgery on intermediate- or high-risk cervical cancer patients received adjuvant radiotherapy
20221 citationsauthor #6
Efficacy and Safety of Recombinant Human Adenovirus Type 5 (H101) in Persistent, Recurrent, or Metastatic Gynecologic Malignancies: A Retrospective Study
202215 citationsauthor #7
Using New Vaginal Doses Evaluation System to Assess the Dose–Effect Relationship for Vaginal Stenosis After Definitive Radio(Chemo)Therapy for Cervical Cancer
20224 citationsauthor #4
Successful treatment of a 19-year-old patient with locally advanced clear cell adenocarcinoma of the uterine cervix using recombinant human adenovirus type 5 (Oncorine) combined with chemoradiotherapy: a case report
20218 citationsauthor #4
Minimally Invasive Versus Open Surgery for Radical Hysterectomy Followed By Adjuvant Radiotherapy in Intermediate- or High-Risk Early-Stage Cancer of The Cervix: A Retrospective Study
20210 citationsauthor #6
Association between preoperative serum TSH and tumor status in patients with papillary thyroid microcarcinoma
20219 citationsauthor #5
Clinical analysis of conformal and intensity-modulated radiotherapy in patients with recurrent ovarian cancer
20206 citationsauthor #4
Activation of STING inhibits cervical cancer tumor growth through enhancing the anti-tumor immune response
202031 citationsauthor #5
Outcomes for hyperthermia combined with concurrent radiochemotherapy for patients with cervical cancer.
202029 citationsauthor #16
Study of Radiotherapy Combined with Concurrent Paclitaxel Liposome or Cisplatin in Elderly Patients with Cervical Cancer
20202 citationsauthor #4
Radiation-induced Vaginal Injury After Treatment for Cervical Cancer
20200 citationsauthor #2
Dosimetric Comparison and Clinical Toxicity in Cervical Cancer Patients Treated with Intensity- Modulated and Three-Dimensional Conformal Radiotherapy: Real-World Data
20200 citationsauthor #3
Retracted Article: RNA-sequencing identified miR-3681 as a negative regulator in the proliferation and migration of cervical cancer cells via the posttranscriptional suppression of HGFR
20192 citationsauthor #6
LncRNA miR143HG Up-Regulates p53 In Endometrial Carcinoma By Sponging miR-125a
201920 citationsauthor #2
Research progress of vaginal radioactivity injury
20190 citationsauthor #3
miR‐144 reverses cisplatin resistance in cervical cancer via targeting LHX2
201927 citationsauthor #5
Vaginal dose of radical radiotherapy for cervical cancer in China: a multicenter study
20194 citationsauthor #3
Upregulated delta-like protein 3 expression is a diagnostic and prognostic marker in endometrial cancer
201815 citationsauthor #4
Kallistatin Suppresses Cell Proliferation and Invasion and Promotes Apoptosis in Cervical Cancer Through Blocking NF-κB Signaling
201720 citationsauthor #1
Peritoneal bladder fistula following radiotherapy for cervical cancer: A case report.
20167 citationsauthor #2
Application of CT-Guided Ad-P53 Intratumoral Injection for Recurrent and Metastatic Gynecologic Cancer Patients Who Received Chemoradiation Therapy.
20160 citationsauthor #2
Association of DNA repair gene polymorphisms with response to cisplatin-based concurrent chemoradiotherapy in patients with cervical carcinoma.
20164 citationsauthor #5
[Progress on clinical application of bevacizumab for the treatment of refractory cervical cancer].
20160 citationsauthor #3
Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer
201653 citationsauthor #1
Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy
20150 citationsauthor #2
Application of 1H NMR spectroscopy-based metabonomics to feces of cervical cancer patients with radiation-induced acute intestinal symptoms.
201528 citationsauthor #3
Genetic alterations of PIK3CA and tumor response in patients with locally advanced cervical squamous cell carcinoma treated with cisplatin-based concurrent chemoradiotherapy.
201518 citationsauthor #3
Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy
201526 citationsauthor #2
A Randomized Controlled Trial Comparing Clinical Outcomes and Toxicity of Lobaplatin- Versus Cisplatin-Based Concurrent Chemotherapy Plus Radiotherapy and High-Dose-Rate Brachytherapy for FIGO Stage II and III Cervical Cancer.
201520 citationsauthor #2
Patient age, tumor appearance and tumor size are risk factors for early recurrence of cervical cancer.
201536 citationsauthor #2
Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
201436 citationsauthor #3
Association Between Bone Marrow Dosimetric Parameters and Acute Hematologic Toxicity in Cervical Cancer Patients Undergoing Concurrent Chemoradiotherapy
201433 citationsauthor #5
Identification of biomarkers for radiation-induced acute intestinal symptoms (RIAISs) in cervical cancer patients by serum protein profiling
20147 citationsauthor #4
Cost-effectiveness of radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
20147 citationsauthor #3
Towards a Trusted Launch Mechanism for Virtual Machines in Cloud Computing
20130 citationsauthor #7
A proposal on auxiliary business insurance for peritoneal dialysis treatment.
20080 citationsauthor #2

TIMELINE

2008 0 citations

2013 0 citations

2014 83 citations

2015 128 citations

2016 64 citations

2017 20 citations

2018 15 citations

2019 53 citations

2020 68 citations

2021 17 citations

2022 20 citations

2023 8 citations

2024 0 citations

2025 2 citations

COAUTHOR MAP

CONCEPT FOOTPRINT